| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |